Skip to main content

Table 4 EPIC questionnaire—urinary

From: Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRI

 

Baseline (n = 99)

1 month (n = 26)

3–4 months (n = 16)

6–9 months (n = 18)

HRQOL Urinary domain summary

    

Mean

83.53

 − 14.13*

0.07

 − 2.96

Standard deviation

13.40

   

MID

6.70

   

Domain-specific HRQOL subscales

    

Function

    

Mean

90.5

 − 10.8*

0.5

 − 1.1

Standard deviation

12.1

   

MID

6.0

   

Bother

    

Mean

79.54

 − 17.45*

 − 1.19

 − 4.94

Standard deviation

17.63

   

MID

8.82

   

Incontinence

    

Mean

88.92

 − 8.30*

1.44

 − 2.07

Standard deviation

16.48

   

MID

8.24

   

Irritative/Obstructive

    

Mean

83.43

 − 16.14*

0.50

 − 4.86

Standard deviation

14.17

   

MID

7.08

   
  1. *Indicates a clinically significant decline in HRQOL based on MID